Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
2,290.00
2,122.50
1,966.40
1,900.70
1,928.80
1,821.70
1,752.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,290.00
2,122.50
1,966.40
1,900.70
1,928.80
1,821.70
1,752.30
Raw Material Cost
642.80
592.10
564.90
520.50
584.00
467.00
469.00
Purchase of Finished goods
84.50
82.00
73.60
73.00
84.80
81.20
69.30
(Increase) / Decrease In Stocks
-14.00
42.20
-42.00
24.70
-42.70
26.20
16.50
Employee Cost
766.90
706.40
636.20
591.10
590.60
560.10
564.30
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
470.50
410.30
392.30
401.80
366.70
399.80
343.80
Total Expenditure (Excl Depreciation)
1,950.70
1,833.00
1,625.00
1,611.10
1,583.40
1,534.30
1,462.90
Operating Profit (PBDIT) excl Other Income
339.30
289.50
341.40
289.60
345.40
287.40
289.40
Other Income
23.70
20.50
9.80
12.00
11.90
9.20
21.70
Operating Profit (PBDIT)
363.00
310.00
351.20
301.60
357.30
296.60
311.10
Interest
56.50
56.10
50.20
49.00
52.70
55.60
61.00
Exceptional Items
-13.70
-39.70
-5.80
0.00
-3.30
-18.90
-14.20
Gross Profit (PBDT)
292.80
214.20
295.20
252.60
301.30
222.10
235.90
Depreciation
116.80
120.70
104.80
98.10
95.20
91.30
91.40
Profit Before Tax
176.00
93.40
190.30
154.40
206.00
130.50
144.40
Tax
56.70
37.60
70.40
51.90
54.70
29.80
41.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
119.30
55.90
120.00
102.60
151.40
101.00
102.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
119.30
55.90
120.00
102.60
151.40
101.00
102.60
Share in Profit of Associates
0.00
-0.10
-0.10
-0.10
-0.10
-0.30
-0.10
Minority Interest
-0.10
-0.10
-0.40
-0.40
-2.30
-0.20
-0.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
119.40
55.90
120.30
102.90
153.60
100.90
102.80
Equity Capital
15.80
15.80
15.80
15.80
15.80
15.80
15.80
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
7.56
3.54
7.61
6.51
9.72
6.39
6.51
Diluted Earnings per share
7.52
3.52
7.57
6.47
9.68
6.36
6.46
Operating Profit Margin (Excl OI)
14.93%
13.68%
17.44%
15.41%
18.03%
15.85%
16.61%
Gross Profit Margin
12.89%
10.12%
15.08%
13.44%
15.73%
12.25%
13.54%
PAT Margin
5.25%
2.64%
6.12%
5.46%
7.9%
5.55%
5.88%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 18.73% vs 9.68% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is -22.27% vs 362.12% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is -1.77% vs 27.27% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 7.21% vs -27.81% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
Compare Quarterly Results Of Jubilant Pharmo With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
2,290.00
739.10
1,550.90
209.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,290.00
739.10
1,550.90
209.84%
Raw Material Cost
642.80
102.80
540.00
525.29%
Purchase of Finished goods
84.50
37.50
47.00
125.33%
(Increase) / Decrease In Stocks
-14.00
14.40
-28.40
-197.22%
Employee Cost
766.90
158.50
608.40
383.85%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
470.50
298.30
172.20
57.73%
Total Expenditure (Excl Depreciation)
1,950.70
611.50
1,339.20
219.00%
Operating Profit (PBDIT) excl Other Income
339.30
127.60
211.70
165.91%
Other Income
23.70
77.80
-54.10
-69.54%
Operating Profit (PBDIT)
363.00
205.40
157.60
76.73%
Interest
56.50
10.90
45.60
418.35%
Exceptional Items
-13.70
0.00
-13.70
Gross Profit (PBDT)
292.80
194.50
98.30
50.54%
Depreciation
116.80
50.40
66.40
131.75%
Profit Before Tax
176.00
144.10
31.90
22.14%
Tax
56.70
-89.20
145.90
163.57%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
119.30
233.30
-114.00
-48.86%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
119.30
233.30
-114.00
-48.86%
Share in Profit of Associates
0.00
35.70
-35.70
-100.00%
Minority Interest
-0.10
1.10
-1.20
-109.09%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
119.40
267.90
-148.50
-55.43%
Equity Capital
15.80
35.80
-20.00
-55.87%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.56
14.97
-7.41
-49.50%
Diluted Earnings per share
7.52
14.96
-7.44
-49.73%
Operating Profit Margin (Excl OI)
14.93%
17.26%
0.00
-2.33%
Gross Profit Margin
12.89%
26.32%
0.00
-13.43%
PAT Margin
5.25%
31.57%
0.00
-26.32%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,290.00 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 7.89% vs 7.94% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 18.73% vs 9.68% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 119.40 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 113.60% vs -53.53% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -22.27% vs 362.12% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 339.30 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 17.20% vs -15.20% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -1.77% vs 27.27% in Mar 2025
Quarterly - Interest
Interest 56.50 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 0.71% vs 11.75% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 7.21% vs -27.81% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.93%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
